blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3668880

EP3668880 - INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.08.2022
Database last updated on 14.11.2024
FormerThe patent has been granted
Status updated on  03.09.2021
FormerGrant of patent is intended
Status updated on  15.03.2021
FormerRequest for examination was made
Status updated on  22.05.2020
FormerThe international publication has been made
Status updated on  22.02.2019
Formerunknown
Status updated on  11.09.2018
Most recent event   Tooltip27.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 30.10.2024  [2024/44]
Applicant(s)For all designated states
Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil / CH
[2020/26]
Inventor(s)01 / BOSS, Christoph
c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil / CH
02 / BUR, Daniel
Im Rosengarten 24
4106 Therwil / CH
03 / CREN, Sylvaine
c/o IdorsiaPharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil / CH
04 / KIMMERLIN, Thierry
c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil / CH
05 / LOTZ-JENNE, Carina
c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil / CH
06 / POTHIER, Julien
c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil / CH
07 / TIDTEN-LUKSCH, Naomi
c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil / CH
 [2020/26]
Representative(s)Velker, Jörg
c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil / CH
[2020/26]
Application number, filing date18759886.716.08.2018
[2020/26]
WO2018EP72187
Priority number, dateWO2017EP7086117.08.2017         Original published format: PCT/EP2017/070861
[2020/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019034725
Date:21.02.2019
Language:EN
[2019/08]
Type: A1 Application with search report 
No.:EP3668880
Date:24.06.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 21.02.2019 takes the place of the publication of the European patent application.
[2020/26]
Type: B1 Patent specification 
No.:EP3668880
Date:06.10.2021
Language:EN
[2021/40]
Search report(s)International search report - published on:EP21.02.2019
ClassificationIPC:C07D513/04, A61K31/429, A61P35/00
[2020/26]
CPC:
C07D513/04 (EP,US); A61K31/429 (EP); A61P35/00 (EP,US);
A61K45/06 (US); Y02A50/30 (EP)
C-Set:
A61K31/429, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/26]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:INHIBITOREN VON INDOLAMIN-2,3-DIOXYGENASE UND/ODER TRYPTOPHAN-2,3-DIOXYGENASE[2020/26]
English:INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE[2020/26]
French:INHIBTEURS DE L'INDOLÉAMINE 2,3-DIOXYGÉNASE ET/OU DU TRYPTOPHANE DIOXYGÉNASE[2020/26]
Entry into regional phase17.03.2020National basic fee paid 
17.03.2020Designation fee(s) paid 
17.03.2020Examination fee paid 
Examination procedure17.03.2020Examination requested  [2020/26]
17.03.2020Date on which the examining division has become responsible
16.03.2021Communication of intention to grant the patent
13.07.2021Fee for grant paid
13.07.2021Fee for publishing/printing paid
13.07.2021Receipt of the translation of the claim(s)
Opposition(s)07.07.2022No opposition filed within time limit [2022/37]
Fees paidRenewal fee
31.08.2020Renewal fee patent year 03
31.08.2021Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.08.2018
AL06.10.2021
AT06.10.2021
CY06.10.2021
CZ06.10.2021
DK06.10.2021
EE06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
MC06.10.2021
MK06.10.2021
MT06.10.2021
NL06.10.2021
PL06.10.2021
RO06.10.2021
RS06.10.2021
SE06.10.2021
SI06.10.2021
SK06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
[2024/44]
Former [2024/27]HU16.08.2018
AL06.10.2021
AT06.10.2021
CY06.10.2021
CZ06.10.2021
DK06.10.2021
EE06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
MC06.10.2021
MK06.10.2021
NL06.10.2021
PL06.10.2021
RO06.10.2021
RS06.10.2021
SE06.10.2021
SI06.10.2021
SK06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2024/24]HU16.08.2018
AL06.10.2021
AT06.10.2021
CY06.10.2021
CZ06.10.2021
DK06.10.2021
EE06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
MC06.10.2021
NL06.10.2021
PL06.10.2021
RO06.10.2021
RS06.10.2021
SE06.10.2021
SI06.10.2021
SK06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2024/21]AL06.10.2021
AT06.10.2021
CY06.10.2021
CZ06.10.2021
DK06.10.2021
EE06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
MC06.10.2021
NL06.10.2021
PL06.10.2021
RO06.10.2021
RS06.10.2021
SE06.10.2021
SI06.10.2021
SK06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2023/16]AL06.10.2021
AT06.10.2021
CZ06.10.2021
DK06.10.2021
EE06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
MC06.10.2021
NL06.10.2021
PL06.10.2021
RO06.10.2021
RS06.10.2021
SE06.10.2021
SI06.10.2021
SK06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2023/01]AL06.10.2021
AT06.10.2021
CZ06.10.2021
DK06.10.2021
EE06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
NL06.10.2021
PL06.10.2021
RO06.10.2021
RS06.10.2021
SE06.10.2021
SI06.10.2021
SK06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2022/49]AL06.10.2021
AT06.10.2021
CZ06.10.2021
DK06.10.2021
EE06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
NL06.10.2021
PL06.10.2021
RO06.10.2021
RS06.10.2021
SE06.10.2021
SK06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2022/35]AT06.10.2021
CZ06.10.2021
DK06.10.2021
EE06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
NL06.10.2021
PL06.10.2021
RO06.10.2021
RS06.10.2021
SE06.10.2021
SK06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2022/34]AT06.10.2021
EE06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
NL06.10.2021
PL06.10.2021
RO06.10.2021
RS06.10.2021
SE06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2022/33]AT06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
NL06.10.2021
PL06.10.2021
RS06.10.2021
SE06.10.2021
SM06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2022/25]AT06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
NL06.10.2021
PL06.10.2021
RS06.10.2021
SE06.10.2021
BG06.01.2022
NO06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2022/24]AT06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
NL06.10.2021
PL06.10.2021
RS06.10.2021
SE06.10.2021
BG06.01.2022
GR07.01.2022
IS06.02.2022
PT07.02.2022
Former [2022/23]AT06.10.2021
FI06.10.2021
HR06.10.2021
LT06.10.2021
LV06.10.2021
PL06.10.2021
RS06.10.2021
BG06.01.2022
PT07.02.2022
Former [2022/22]AT06.10.2021
FI06.10.2021
LT06.10.2021
RS06.10.2021
BG06.01.2022
Former [2022/21]AT06.10.2021
RS06.10.2021
BG06.01.2022
Former [2022/19]BG06.01.2022
Cited inInternational search[A]WO2011037780  (MERCK SHARP & DOHME [US], et al) [A] 1-13* data on pages 63-66; page 17, paragraph 2; claims 1,16,17,24; table 1 *;
 [AD]WO2016161960  (BEIGENE LTD, et al) [AD] 1-13 * claims 1,25-30; tables 1,2 *;
 [AD]WO2017134555  (EMCURE PHARMACEUTICALS LTD [IN]) [AD] 1-13 * claims 1,5-12 *
by applicantWO2010005958
 WO2012142237
 WO2015033299
 WO2015034820
 WO2015044900
 WO2015173764
 WO2016073770
 WO2016161960
 WO2017007700
 WO2017134555
 WO2017133258
 WO2017189386
 CN107556244
 WO2018036414
 WO2018057973
 WO2018054365
 WO2018136887
    - CHEMICAL ABSTRACTS, Database accession no. 2169203-74-9
    - PILOTTE et al., Proc Natl Acad Sci., (20120000), vol. 109, no. 7, pages 2497 - 502
    - D'AMATO et al., Cancer Res., (20150000), vol. 75, no. 21, pages 4651 - 64
    - UYTTENHOVE et al., Nat Med., (20030000), vol. 9, no. 10, pages 1269 - 74
    - THEATE et al., Cancer Immunol Res., (20150000), vol. 3, no. 2, pages 161 - 72
    - MUNN; MELLOR, Trends in Immunol., (20160000), vol. 37, no. 3, pages 193 - 207
    - LIU et al., Blood, (20100000), vol. 115, no. 17, pages 3520 - 30
    - FERNS et al., Oncoimmunology, (20150000), vol. 4, no. 2, page e981457
    - ZHAI et al., Clin Cancer Res., (20150000), vol. 21, no. 24, pages 5427 - 33
    - MULLER et al., Proc Natl Acad Sci USA., (20080000), vol. 105, no. 44, pages 17073 - 8
    - HOLMGAARD et al., Cell Rep., (20150000), vol. 13, no. 2, pages 412 - 24
    - BALACHANDRAN et al., Nat Med., (20110000), vol. 17, no. 9, pages 1094 - 100
    - OPITZ et al., Nature, (20110000), vol. 478, no. 7368, pages 197 - 203
    - LIN et al., J Med Chem., (20160000), vol. 59, no. 1, pages 419 - 30
    - KOBLISH et al., Mol Cancer Ther., (20100000), vol. 9, no. 2, pages 489 - 98
    - YUE et al., J Med Chem., (20090000), vol. 52, no. 23, pages 7364 - 7
    - YANG et al., J Med Chem., (20130000), vol. 56, no. 21, pages 8321 - 31
    - HANIHARA et al., J Neurosurg., (20160000), vol. 124, no. 6, pages 1594 - 601
    - HOU et al., Cancer Res., (20070000), vol. 67, no. 2, pages 792 - 801
    - LI et al., Journal Immunother Cancer, (20140000), vol. 2, page 21
    - SPRANGER et al., J Immunother Cancer, (20140000), vol. 2, page 3
    - HOLMGAARD et al., J Exp Med., (20130000), vol. 210, no. 7, pages 1389 - 402
    - WAINWRIGHT et al., Clin Cancer Res., (20140000), vol. 20, no. 20, pages 5290 - 301
    - HOLMGAARD et al., EBioMedicine, (20160000), vol. 6, pages 50 - 8
    - NINOMIYA et al., Blood, (20150000), vol. 125, no. 25, pages 3905 - 16
    - LEMOS et al., Cancer Res., (20160000), vol. 76, no. 8, pages 2076 - 81
    - THEVANDAVAKKAM et al., CNS Neurol Disord. Drug Targets., (20100000), vol. 9, no. 6, pages 791 - 800
    - ISHII et al., Arch Biochem Biophys., (19920000), vol. 294, no. 2, pages 616 - 622
    - HIRAKU et al., Carcinogenesis, (19950000), vol. 16, no. 2, pages 349 - 56
    - STONE; PERKINS, Eur J Pharmacol., (19810000), vol. 72, no. 4, pages 411 - 2
    - SCHWARCZ et al., Science, (19830000), vol. 219, no. 4582, pages 316 - 8
    - VECSEI; BEAL, Brain Res Bull., (19900000), vol. 25, no. 4, pages 623 - 7
    - FOSTER et al., Neurosci Lett., (19840000), vol. 48, no. 3, pages 273 - 8
    - CARPENEDO et al., Eur J Neurosci., (20010000), vol. 13, no. 11, pages 2141 - 7
    - GODA et al., Adv. Exp. Med. Biol., (19990000), vol. 467, pages 397 - 402
    - GUILLEMIN et al., Redox Rep, (20000000), vol. 5, no. 2-3, pages 108 - 11
    - LIM et al., International Congress Series., (20070000), vol. 1304, pages 213 - 7
    - SALTER; POGSON, Biochem J., (19850000), vol. 229, no. 2, pages 499 - 504
    - MILLER et al., Neurobiol Dis., (20040000), vol. 15, no. 3, pages 618 - 29
    - GRAVES et al., Amyotroph Lateral Scler Other Motor Neuron Disord., (20040000), vol. 5, no. 4, pages 213 - 9
    - HENKEL et al., Ann Neurol, (20040000), vol. 55, no. 2, pages 221 - 35
    - MCGEER; MCGEER, Muscle Nerve., (20020000), vol. 26, no. 4, pages 459 - 70
    - CHEN et al., Neurotox Res., (20100000), vol. 18, no. 2, pages 132 - 42
    - FORREST et al., Neurochem, (20100000), vol. 112, no. 1, pages 112 - 22
    - SAPKO et al., Exp Neurol., (20060000), vol. 197, no. 1, pages 31 - 40
    - CAMPESAN et al., Curr Biol., (20110000), vol. 21, no. 11, pages 961 - 6
    - GUILLEMIN et al., Redox Rep., (20020000), vol. 7, no. 4, pages 199 - 206
    - WALKER et al., J Leukoc Biol., (20060000), vol. 79, pages 596 - 610
    - GUILLEMIN et al., Neuropathol Appl Neurobiol., (20050000), vol. 31, no. 4, pages 395 - 404
    - RAHMAN et al., PLOS One., (20090000), vol. 4, no. 7, page e6344
    - WU et al., PLOS One, (20130000), vol. 8, no. 4, page e59749
    - WIDNER et al., J Neural Transm (Vienna, (20000000), vol. 107, no. 3, pages 343 - 53
    - BREDA et al., Proc Natl Acad Sci., (20160000), vol. 113, no. 19, pages 5435 - 40
    - GAO; HONG, Trends Immunol., (20080000), vol. 29, no. 8, pages 357 - 65
    - BLOCK et al., Nat Rev Neurosci., (20070000), vol. 8, no. 1, pages 57 - 69
    - OKUDA et al., J Neurochem., (19980000), vol. 70, no. 1, pages 299 - 307
    - STONE A; PERKINS, Eur J Pharmacol., (19810000), vol. 72, no. 4, pages 411 - 2
    - BRAIDY et al., Neurotox Res., (20090000), vol. 16, no. 1, pages 77 - 86
    - JHAMANDAS et al., Brain Res., (19900000), vol. 529, no. 1-2, pages 185 - 91
    - TRAPP et al., Curr Opin Neurol., (19990000), vol. 12, pages 295 - 302
    - OWENS, Curr Opin Neurol., (20030000), vol. 16, pages 259 - 265
    - FLANAGAN et al., J Neurochem., (19950000), vol. 64, pages 1192 - 6
    - GUILLEMIN et al., J Interferon Cytokine Res., (20010000), vol. 21, pages 1097 - 1101
    - AMIRKHANI et al., Eur. J. Neurol., (20050000), vol. 12, pages 625 - 31
    - CAMMER et al., Brain Res., (20010000), vol. 896, pages 157 - 160
    - HOLTZE et al., J Psychiatry Neurosci., (20120000), vol. 37, no. 1, pages 53 - 7
    - BARRY et al., J Psychopharmacol., (20090000), vol. 23, no. 3, pages 287 - 94
    - MILLER et al., Brain Res., (20060000), vol. 1073-107, pages 25 - 37
    - MILLER et al., Neurochem Int., (20080000), vol. 52, no. 6, pages 1297 - 303
    - DANTZER et al., Nat Rev Neurosci., (20080000), vol. 9, no. 1, pages 46 - 56
    - SULLIVAN et al., Pain, (19920000), vol. 50, no. 1, pages 5 - 13
    - HEYES et al., Brain, (19920000), vol. 115, pages 1249 - 73
    - KIM et al., J Clin Invest., (20120000), vol. 122, no. 8, pages 2940 - 54
    - YAN et al., Journal of Neuroinflammation, (20150000), vol. 12, no. 110, pages 1 - 17
    - HOSHI et al., J Immunol., (20100000), vol. 185, no. 6, pages 3305 - 3312
    - VAN DER SLUIJS et al., J Infect Dis., (20060000), vol. 193, no. 2, pages 214 - 22
    - SUZUKI et al., J Infect., (20110900), vol. 63, no. 3, pages 215 - 22
    - MARANON et al., Parasite Immunol., (20130000), vol. 35, no. 5-6, pages 180 - 7
    - BARTH; RAGHURAMAN, Crit Rev Microbiol., (20140000), vol. 40, no. 4, pages 360 - 8
    - SUZUKI et al., Clin Vaccine Immunol., (20120000), vol. 19, no. 3, pages 436 - 442
    - MURRAY, Lancet Infect Dis., (20030000), vol. 3, no. 10, pages 644 - 52
    - KANDANEARATCHI; BREW, FEBS J., (20120000), vol. 279, no. 8, pages 1366 - 74
    - STONE; DARLINGTON, Trends Pharmacol Sci., (20130000), vol. 34, no. 2, pages 136 - 43
    - LARREA et al., J Virol., (20070000), vol. 81, no. 7, pages 3662 - 6
    - ASGHAR et al., Exp Ther Med., (20150000), vol. 9, no. 3, pages 901 - 4
    - HARRINGTON et al., Infect Immunol., (20080000), vol. 76, no. 7, pages 3045 - 53
    - LAURANS et al., Nature Medicine, (20180000), URL: https://doi.org/10.1038/s41591-018-00604
    - NATIVIDAD et al., Cell Metabolism, (20180000), vol. 28, pages 1 - 13
    - TAKIKAWA et al., Adv Exp Med Biol., (19990000), vol. 467, pages 241 - 5
    - TAYLOR et al., Exp Eye Res., (20020000), vol. 75, no. 2, pages 165 - 75
    - MAILANKOT et al., Lab Invest., (20090000), vol. 89, no. 5, pages 498 - 512
    - BURNEY et al., Endocrinology., (20070000), vol. 148, no. 8, pages 3814 - 26
    - AGHAJANOVA et al., Reprod Sci., (20110000), vol. 18, no. 3, pages 229 - 251
    - MEI et al., Int J Clin Exp Pathol., (20130000), vol. 6, no. 3, pages 431 - 44
    - MUNN et al., Science, (19980000), vol. 281, no. 5380, pages 1191 - 3
    - DURR; KINDLER, J Leukoc Biol., (20130000), vol. 93, no. 5, pages 681 - 700
    - TANKIEWICZ et al., Adv Exp Med Biol., (20030000), vol. 527, pages 409 - 14
    - SALA et al., J Biol Chem., (20040000), vol. 279, no. 49, pages 51033 - 41
    - WIRLEITNER et al., Eur J Clin Invest., (20030000), vol. 33, no. 7, pages 550 - 4
    - FORREST et al., J. Neurochem., vol. 119, no. 1, pages 136 - 52
    - CUARTERO et al., Curr Pharm Des., (20160000), vol. 22, no. 8, pages 1060 - 1073
    - J. Med. Chem., (19960000), vol. 39, pages 957 - 967
    - Biochem et Biophysica Acta, (20110000), vol. 1814, pages 1947 - 1954
    - Acta Cryst., (20100000), vol. D66, pages 125 - 132
    - J. Appl. Cryst., (20070000), vol. 40, pages 658 - 674
    - Acta Cryst., (20040000), vol. D60, pages 2284 - 2295
    - COOT, Acta Cryst., (20100000), vol. D66, pages 486 - 501
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.